These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5085172)

  • 21. The effect of organic compounds on the crystal habit and crystallization of normal and sickle cell hemoglobin in phosphate buffer.
    Farnell KJ; McMeekin TL
    Arch Biochem Biophys; 1973 Oct; 158(2):702-10. PubMed ID: 4782530
    [No Abstract]   [Full Text] [Related]  

  • 22. Biochemical and physiological properties of carbamylated hemoglobin S.
    Manning JM; Cerami A; Gillette PN; De Furia FG; Miller DR
    Adv Enzymol Relat Areas Mol Biol; 1974; 40(0):1-27. PubMed ID: 4600763
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitation of hemoglobins A and S separated by starch gel electrophoresis.
    Perry BW; Hill RJ
    Anal Biochem; 1968 Jan; 22(1):21-6. PubMed ID: 5636954
    [No Abstract]   [Full Text] [Related]  

  • 24. Pyridoxal phosphate as an antisickling agent in vitro.
    Kark JA; Tarassoff PG; Bongiovanni R
    J Clin Invest; 1983 May; 71(5):1224-9. PubMed ID: 6853710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dehydration and delayed proton equilibria of red blood cells suspended in isosmotic phosphate buffers. Implications for studies of sickled cells.
    Bookchin RM; Lew DJ; Balazs T; Ueda Y; Lew VL
    J Lab Clin Med; 1984 Dec; 104(6):855-66. PubMed ID: 6094692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of urea and cyanate on sickling in vitro.
    Segel GB; Feig SA; Mentzer WC; McCaffrey RP; Wells R; Bunn HF; Shohet SB; Nathan DG
    N Engl J Med; 1972 Jul; 287(2):59-64. PubMed ID: 5031386
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of cyanate on sickling.
    May A; Bellingham AJ; Huehns ER; Beaven GH
    Lancet; 1972 Mar; 1(7752):658-61. PubMed ID: 4125163
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on abnormal hemoglobins. VII. The composition of the non-S hemoglobin fraction in sickle-cell anemia bloods; a comparative quantitative study by the methods of electrophoresis and alkali denaturation.
    SINGER K; FISHER B
    J Lab Clin Med; 1953 Aug; 42(2):193-204. PubMed ID: 13069865
    [No Abstract]   [Full Text] [Related]  

  • 29. Oxygen affinity independent action of cyanate and 2,3 DPG on sickling.
    Jensen MC; Bunn HF; Halikas GC; Nathan DG
    Adv Exp Med Biol; 1972; 28():297-302. PubMed ID: 5085173
    [No Abstract]   [Full Text] [Related]  

  • 30. Noncovalent modification of deoxyhemoglobin S solubility and erythrocyte sickling.
    Waterman MR; Yamaoka K; Dahm L; Taylor J; Cottam GL
    Proc Natl Acad Sci U S A; 1974 Jun; 71(6):2222-5. PubMed ID: 4526343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemoglobin Ocho Rios ( beta52 (D3) aspartic acid leads to alanine): a new beta-chain variant of haemoglobin A found in combination with haemoglobin S.
    Beresford CH; Clegg JB; Weatherall DJ
    J Med Genet; 1972 Jun; 9(2):151-3. PubMed ID: 5046622
    [No Abstract]   [Full Text] [Related]  

  • 32. Zone electrophoresis of abnormal hemoglobins; separation on paper of hemoglobins associated with sickle cell disease.
    BERGREN WR; STURGEON P; ITANO HA
    Acta Haematol; 1954 Sep; 12(3):160-8. PubMed ID: 13196930
    [No Abstract]   [Full Text] [Related]  

  • 33. Cyanate as an inhibitor of red-cell sickling.
    Cerami A
    N Engl J Med; 1972 Oct; 287(16):807-12. PubMed ID: 4560520
    [No Abstract]   [Full Text] [Related]  

  • 34. Red cells shrink during sickling.
    Masys DR; Bromberg PA; Balcerzak SP
    Blood; 1974 Dec; 44(6):885-9. PubMed ID: 4429804
    [No Abstract]   [Full Text] [Related]  

  • 35. RATE OF SICKLING OF RED CELLS DURING DEOXYGENATION OF BLOOD FROM PERSONS WITH VARIOUS SICKLING DISORDERS.
    CHARACHE S; CONLEY CL
    Blood; 1964 Jul; 24():25-48. PubMed ID: 14194270
    [No Abstract]   [Full Text] [Related]  

  • 36. Conformational changes induced by the addition of carbamyl phosphate to sickle cell hemoglobin.
    Chapman CE; Simons ER
    Biochim Biophys Acta; 1977 Oct; 494(2):408-15. PubMed ID: 911880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. THE METABOLISM OF THE INDIVIDUAL C14 LABELED HEMOGLOBINS IN PATIENTS WITH H-THALASSEMIA, WITH OBSERVATIONS ON RADIOCHROMATE BINDING TO THE HEMOGLOBINS DURING RED CELL SURVIVAL.
    GABUZDA TG; NATHAN DG; GARDNER FH
    J Clin Invest; 1965 Feb; 44(2):315-25. PubMed ID: 14260170
    [No Abstract]   [Full Text] [Related]  

  • 38. Hemoglobin Memphis/S. A new variant of sickle cell anemia.
    Kraus AP; Miyaji T; Iuchi I; Kraus LM
    Trans Assoc Am Physicians; 1967; 80():297-304. PubMed ID: 6082248
    [No Abstract]   [Full Text] [Related]  

  • 39. The solubility of hemoglobin beta 4 S, the mutant subunits of sickle cell hemoglobin.
    Benesch R; Benesch RE; Yung S
    Biochem Biophys Res Commun; 1973 Nov; 55(2):261-5. PubMed ID: 4767302
    [No Abstract]   [Full Text] [Related]  

  • 40. Haemoglobin D Punjab in a Cuban family and its interaction with haemoglobin S.
    Uriarte A; Perez Atencio R; Colombo B
    Acta Haematol; 1973; 50(5):315-20. PubMed ID: 4202636
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.